Survey: Medtech firms could cut jobs, R&D to manage device tax

02/22/2013 | MassDevice.com (Boston)

An Emergo Group survey of 650 senior medtech executives found that 11% would shrink their workforce to help manage the costs of the 2.3% medical device tax, while about 12% would cut their research and development funding. Meanwhile, more than 40% of respondents said they would deal with the tax by raising product prices.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC